HOME › DRUGS › IMATINIB MESYLATE
ACTIVE SUBSTANCE / INN

IMATINIB MESYLATE

Brand name(s): IMKELDI, IMATINIB MESYLATE, GLEEVEC
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA207495
NDA219097
ACTIVE SUBSTANCE
Imatinib Mesylate
REGULATORS
FDA
SPONSORS / MAH
NOVARTIS, AMNEAL PHARMS, SHORLA ONCOLOGY
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
IMKELDINDA219097SHORLA ONCOLOGYPrescription
GLEEVECNDA021588NOVARTISPrescription
IMATINIB MESYLATEANDA210658ZYDUS PHARMSPrescription
GLEEVECNDA021335NOVARTISDiscontinued
IMATINIB MESYLATEANDA207495AMNEAL PHARMSDiscontinued

FULL INTELLIGENCE ON IMATINIB MESYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →